Celularity Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019
Net Income	14.19	-100.12	-208.23	-211.88
Depreciation & Amortization	9.38	8.82	8.17	6.19
Share-Based Compensation	15.86	40.01	4.37	3.67
Other Operating Activities	-177.3	-58.81	132.5	135.23
Operating Cash Flow	-137.88	-110.1	-63.19	-66.79
Capital Expenditures	-5.24	-6.2	-27.83	-31.47
Acquisitions	0	0	15.02	0
Change in Investments	0	0.3	0	0
Investing Cash Flow	-5.24	-5.9	-12.82	-31.47
Share Issuance / Repurchase	83.87	109.42	-0.12	0.08
Debt Issued / Paid	39.2	0	0	0
Other Financing Activities	-3.23	-10.86	102.13	119.18
Financing Cash Flow	119.84	98.56	102.01	119.25
Net Cash Flow	-23.27	-17.44	26.01	20.99
Free Cash Flow	-143.11	-116.3	-91.03	-98.27
Free Cash Flow Margin	-796.17%	-545.11%	-637.53%	-464.69%
Free Cash Flow Per Share	-10.23	-17.34	-49.42	-41.16

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).